UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

       Date of Report: (Date of earliest event reported) November 30, 2016


                           UNITED CANNABIS CORPORATION
                  -------------------------------------------
               (Exact name of registrant as specified in charter)


                                    Colorado
                ------------------------------------------------
         (State or other Jurisdiction of Incorporation or Organization)


                              1600 Broadway, Suite 1600
      000-54582                    Denver, CO 80202               46-5221947
-----------------------   -----------------------------------  -----------------
   (Commission File        (Address of Principal Executive       (IRS Employer
       Number)                         Offices                  Identification
                                    and Zip Code)                   Number)


                                 (303) 386-7321
                  -------------------------------------------
              (Registrant's telephone number, including area code)


                                       N/A
              ----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing  obligation  of  registrant  under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
    CFR 240.14a-12(b))

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))

<PAGE>

Item 8.01   Other Events

     On December  18, 2014 the Company  issued a $600,000  unsecured  promissory
note, bearing interest at 12% per year, to Slainte Ventures, LLC.

     The note was subsequently amended such that:

     o    the maturity date of the note was extended to December 30, 2017;

     o    with the  agreement of the Company,  the note could be converted  into
          shares of the Company's common stock; and

     o    a warrant, in lieu of interest due on the loan, was issued to Slainte.
          The  warrant is  exercisable  at a price of $0.18 per share and can be
          exercised  at any time during the five year period  ending on November
          30, 2021.

     The  number  of  shares  to be  issued  upon a  conversion  of the note was
determined by dividing the dollar amount of the principal to be converted by the
Conversion  Price.  The Conversion Price was 70% of the average closing price of
the Company's common stock for the ten business days  immediately  preceding the
date of the Conversion.

     Slainte has since  converted the entire  principal  amount of the Note into
594,540 shares of the Company's common stock.

     Following the note  conversion,  Slainte  purchased  104,939  shares of the
Company's common stock for $100,000.

     The Company relied upon the exemption from registration provided by Section
4(a)2  of the  Securities  Act of  1933  with  respect  to the  issuance  of the
securities  described above. The purchaser of these securities was an accredited
investor who was provided full information  regarding the Company's business and
operations.  There was no general  solicitation  in connection with the offer or
sale of these  securities.  The purchaser  acquired these securities for its own
account.  The  securities  cannot  be  sold  unless  pursuant  to  an  effective
registration statement or an exemption from registration.

Item 3.02.  Unregistered Sales of Equity Securities

     See Item 8.01 of this report.

                                       2
<PAGE>



                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: December 9, 2016
                                     UNITED CANNABIS CORPORATION


                                     By: /s/ Ernie Blackmon
                                         --------------------------------------
                                         Ernie Blackmon, Chief Executive Officer
[{"type": "8-K", "sequence": "1", "filename": "form8k801slainte12-16.txt", "description": "8-K RE SLAINTE NOTE", "secsgml_size_bytes": 4828}]
{"company-data": {"conformed-name": "United Cannabis Corp", "cik": "0001436161", "assigned-sic": "2834", "irs-number": "261391338", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54582", "film-number": "162045058"}, "business-address": {"street1": "1600 BROADWAY", "street2": "SUITE 1600", "city": "DENVER", "state": "CO", "zip": "80202", "phone": "(407) 432-2547"}, "mail-address": {"street1": "1600 BROADWAY", "street2": "SUITE 1600", "city": "DENVER", "state": "CO", "zip": "80202"}, "former-company": {"former-conformed-name": "MySkin, Inc.", "date-changed": "20080528"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

       Date of Report: (Date of earliest event reported) November 30, 2016

                           UNITED CANNABIS CORPORATION
                  -------------------------------------------
               (Exact name of registrant as specified in charter)

                                    Colorado
                ------------------------------------------------
         (State or other Jurisdiction of Incorporation or Organization)

                              1600 Broadway, Suite 1600
      000-54582                    Denver, CO 80202               46-5221947
-----------------------   -----------------------------------  -----------------
   (Commission File        (Address of Principal Executive       (IRS Employer
       Number)                         Offices                  Identification
                                    and Zip Code)                   Number)

                                 (303) 386-7321
                  -------------------------------------------
              (Registrant's telephone number, including area code)

                                       N/A
              ----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing  obligation  of  registrant  under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
    CFR 240.14a-12(b))

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))
Item 8.01   Other Events

     On December  18, 2014 the Company  issued a $600,000  unsecured  promissory
note, bearing interest at 12% per year, to Slainte Ventures, LLC.

     The note was subsequently amended such that:

     o    the maturity date of the note was extended to December 30, 2017;

     o    with the  agreement of the Company,  the note could be converted  into
          shares of the Company's common stock; and

     o    a warrant, in lieu of interest due on the loan, was issued to Slainte.
          The  warrant is  exercisable  at a price of $0.18 per share and can be
          exercised  at any time during the five year period  ending on November
          30, 2021.

     The  number  of  shares  to be  issued  upon a  conversion  of the note was
determined by dividing the dollar amount of the principal to be converted by the
Conversion  Price.  The Conversion Price was 70% of the average closing price of
the Company's common stock for the ten business days  immediately  preceding the
date of the Conversion.

     Slainte has since  converted the entire  principal  amount of the Note into
594,540 shares of the Company's common stock.

     Following the note  conversion,  Slainte  purchased  104,939  shares of the
Company's common stock for $100,000.

     The Company relied upon the exemption from registration provided by Section
4(a)2  of the  Securities  Act of  1933  with  respect  to the  issuance  of the
securities  described above. The purchaser of these securities was an accredited
investor who was provided full information  regarding the Company's business and
operations.  There was no general  solicitation  in connection with the offer or
sale of these  securities.  The purchaser  acquired these securities for its own
account.  The  securities  cannot  be  sold  unless  pursuant  to  an  effective
registration statement or an exemption from registration.

Item 3.02.  Unregistered Sales of Equity Securities

     See Item 8.01 of this report.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: December 9, 2016
                                     UNITED CANNABIS CORPORATION

                                     By: /s/ Ernie Blackmon
                                         --------------------------------------
                                         Ernie Blackmon, Chief Executive Officer